APT Medical Inc. carries a market capitalization of 28.42B, placing it among publicly traded companies globally. Its enterprise value stands at 40.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 28.42B |
| Enterprise Value | 40.69B |
APT Medical Inc. currently has 141.01M shares outstanding.
| Shares Outstanding | 141.01M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
APT Medical Inc. trades at a trailing price-to-earnings ratio of 55.37. The price-to-sales ratio is 18.36, and the price-to-book ratio stands at 20.57.
| PE Ratio | 55.37 |
| PS Ratio | 18.36 |
| PB Ratio | 20.57 |
| P/TBV Ratio | 17.54 |
| P/FCF Ratio | 122.49 |
| P/OCF Ratio | N/A |
On an enterprise value basis, APT Medical Inc. trades at an EV/EBITDA multiple of 47.89 and an EV/FCF ratio of 118.68. The EV/Sales ratio of 17.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 47.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 17.86 |
| EV / EBITDA | 47.89 |
| EV / EBIT | 47.89 |
| EV / FCF | 118.68 |
APT Medical Inc. maintains a current ratio of 5.12, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.54, indicating moderate leverage, while an interest coverage ratio of 615.82 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.12 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 615.82 |
APT Medical Inc. posts a return on equity of 44.21 and a return on invested capital of 29.31.
| Return on Equity (ROE) | 44.21 |
| Return on Assets (ROA) | 25.34 |
| Return on Invested Capital (ROIC) | 29.31 |
| Return on Capital Employed (ROCE) | 43.80 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.54 |
Over the trailing twelve months, APT Medical Inc. has paid 98.02M in income taxes, reflecting an effective tax rate of 11.71.
| Income Tax | 98.02M |
| Effective Tax Rate | 11.71 |
APT Medical Inc.'s stock has declined approximately -25.49643% over the past 52 weeks. The 50-day moving average sits at 239.08, while the 200-day moving average is 258.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | -25.49643% |
| 50-Day Moving Average | 239.08 |
| 200-Day Moving Average | 258.95 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, APT Medical Inc. generated 2.28B in revenue and converted that into 755.75M in net income, yielding earnings per share of 5.25. EBITDA reached 849.52M, while operating income came in at 849.52M.
| Revenue | 2.28B |
| Gross Profit | 1.66B |
| Operating Income | 849.52M |
| Pretax Income | 837.04M |
| Net Income | 755.75M |
| EBITDA | 849.52M |
| EBIT | 849.52M |
| Earnings Per Share (EPS) | 5.25 |
APT Medical Inc. holds 1.21B in cash and equivalents against 15.32M in total debt, resulting in a net debt position of -1.08B. Total book value stands at 2.03B, with working capital of 1.43B providing operational flexibility.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 15.32M |
| Net Debt | -1.08B |
| Equity (Book Value) | 2.03B |
| Book Value Per Share | 14.44 |
| Working Capital | 1.43B |
After subtracting -341.61M in capital expenditures, free cash flow totaled -341.61M - equivalent to -2.42 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -341.61M |
| Free Cash Flow | -341.61M |
| FCF Per Share | -2.42 |
APT Medical Inc. operates with a gross margin of 72.76, reflecting its pricing power and cost economics. The operating margin of 37.28 and net profit margin of 33.17 provide insight into operational efficiency.
| Gross Margin | 72.76 |
| Operating Margin | 37.28 |
| Pretax Margin | 36.73 |
| Profit Margin | 33.17 |
| EBITDA Margin | 37.28 |
The company's payout ratio of 42.10 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 2.16 |
| Dividend Yield | N/A |
| Payout Ratio | 42.10 |
| Shareholder Yield | 0.77 |
| FCF Yield | 0.82 |
APT Medical Inc.'s most recent stock split took place on July 26, 2024 with a 20:29 split ratio.
| Last Split Date | 7/26/2024 |
| Split Ratio | 20:29 |
APT Medical Inc. posts an Altman Z-Score of 67.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 67.25 |